Brn-3a is a member of the POU family of transcription factors which is
expressed predominantly in neuronal cells. It exists in two forms, wi
th the long form containing 84 amino acids at the N-terminus which are
lacking in the short form. The N-terminal domain unique to the long f
orm allows it to induce expression of the Bcl-2 gene and protect neuro
nal cells from apoptosis whereas the C-terminal POU domain common to b
oth forms is sufficient for activating a number of other neuronally ex
pressed genes and stimulating neuronal pl-oct:ss outgrowth. These effe
cts of Brn-3a suggest that manipulation of its expression by pharmacol
ogical or gene therapy procedures may be of benefit in human neurologi
cal diseases. (C) 1998 Published by Elsevier Science Ltd. All rights r
eserved.